News

Filter

126 to 135 of 531 results

Teva fleshes out restructuring plan; licenses Xenon pain drug for $376 million

12-12-2012

Teva Pharmaceutical Industries (NYSE: TEVA's new chief executive Jeremy Levin has outlined the company's…

CopaxoneFinancialGenericsLicensingPatentsPharmaceuticalResearchTeva Pharmaceutical IndustriesXenon Pharmaceuticals

Galena Biopharma leaps on deal with Teva for NeuVax in Israel

05-12-2012

Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading…

BiotechnologyGalena BioPharmaLicensingnelipepimut-SNeuVaxOncologyRest of the WorldTeva Pharmaceutical IndustriesVaccines

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva

03-12-2012

Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before…

BioCryst PharmaceuticalsFinancialHomeMergers & AcquisitionsNestlePfizerPresidio PharmaceuticalsTeva Pharmaceutical Industries

Teva to raise stake in Rexahn; Pfizer completes NextWave deal

28-11-2012

US clinical-stage biopharma company focused on oncology and central nervous system (CNS) therapeutics…

Mergers & AcquisitionsNeurologicalNextWave PharmaceuticalsNorth AmericaOncologyPfizerPharmaceuticalQuillivantResearchRexahn PharmaceuticalsRX-3117Teva Pharmaceutical Industries

XTL Biopharma buys Teva's stake in Proteologics

28-11-2012

In a second M&A deal this year, Israel's XTL Biopharmaceuticals (TASE: XTL) announced that it has acquired…

Mergers & AcquisitionsPharmaceuticalProteologicsTeva Pharmaceutical IndustriesXTL Biopharmaceuticals

Novogen to acquire Triaxial Pharma for $1.8 million; EU approves Teva/P&G deal

13-11-2012

Biotechnology firm Novogen (ASX: NRT) yesterday announced that it has signed a term sheet in relation…

BiotechnologyMergers & AcquisitionsNovogenPharmaceuticalProcter & GambleRegulationTeva Pharmaceutical IndustriesTriaxial Pharmaceuticals

Canada's Supreme Court paves way for generic Viagra

09-11-2012

There was disappointing news for global pharma behemoth Pfizer (NYSE: PFE) yesterday, when the Canadian…

GenericsLegalMen's HealthNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesViagra

Two senior management appointments at Teva

06-11-2012

Israel-headquartered Teva Pharmaceutical Industries (NYSE: TEVA) yesterday announced two management changes…

GenericsManagementTeva Pharmaceutical Industries

Teva Pharma's earnings beat forecasts, but sales lower than expected

02-11-2012

Israel-headquartered Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs maker…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

126 to 135 of 531 results

COMPANY SPOTLIGHT

Menarini

Back to top